|
APTOF Aptose Biosciences Inc 882361 |
| Income Statement |
|
Net Income
|
2026-03-31
|
$-7,634,000.00 |
| Balance Sheet |
|
Current Assets
|
$6,155,000.00 |
|
Assets
|
$10,723,000.00 |
|
Current Liabilities
|
$11,239,000.00 |
|
Liabilities
|
$45,395,000.00 |
|
Equity
|
$-34,672,000.00 |
|
Shares Out
|
2552429.00 |
| Cash Flow Statement |
|
Operating Cash Flow
|
$-5,841,000.00 |
| Market Analysis |
Market Cap
|
$4,313,605.01 |
|
Price
|
$1.69 |
|
PB
|
5.29 |
|
EPS
|
-2.99 |
|
FCF
|
$-5,841,000.00 |
|
| Dividends |
|
Dividend Data Last Updated
|
2026-08-01 09:31:47 |
|
|
| Earnings |
|
Earnings Last Updated
|
2026-08-03 10:01:48 |
|
|
|
Find a discrepancy? The most accurate way to find company fundamental data is to view APTOF documents filed with the SEC.
APTOF Filings
Clear
